Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: Current status and recommendations for future research
Andrew J. Saykin, Michiel B. de Ruiter, Brenna C. McDonald, et al.
Brain Imaging and Behavior (2013) Vol. 7, Iss. 4, pp. 363-373
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Radiation-induced brain injury: current concepts and therapeutic strategies targeting neuroinflammation
Casmir Turnquist, Brent T. Harris, Curtis C. Harris
Neuro-Oncology Advances (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 147
Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012
Florence Joly, Bénédicte Giffard, Olivier Rigal, et al.
Journal of Pain and Symptom Management (2015) Vol. 50, Iss. 6, pp. 830-841
Open Access | Times Cited: 153
Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: A systematic review
Mingmei Li, Karen Caeyenberghs
Neuroscience & Biobehavioral Reviews (2018) Vol. 92, pp. 304-317
Closed Access | Times Cited: 107
Cognitive Effects of Cancer Systemic Therapy: Implications for the Care of Older Patients and Survivors
Jeanne S. Mandelblatt, Paul B. Jacobsen, Tim A. Ahles
Journal of Clinical Oncology (2014) Vol. 32, Iss. 24, pp. 2617-2626
Open Access | Times Cited: 103
Long-Term Cognitive Dysfunction in Cancer Survivors
Zuzana Országhová, Michal Mego, Michal Chovanec
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 102
Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions
S.B. Schagen, Martin Klein, Jaap C. Reijneveld, et al.
European Journal of Cancer Supplements (2014) Vol. 12, Iss. 1, pp. 29-40
Open Access | Times Cited: 97
Pharmacologic management of cognitive impairment induced by cancer therapy
Philipp Karschnia, Michael W. Parsons, Jörg Dietrich
The Lancet Oncology (2019) Vol. 20, Iss. 2, pp. e92-e102
Closed Access | Times Cited: 92
International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients
Sabine Deprez, Shelli R. Kesler, Andrew J. Saykin, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 110, Iss. 3, pp. 223-231
Open Access | Times Cited: 84
Predicting Long-Term Cognitive Outcome Following Breast Cancer with Pre-Treatment Resting State fMRI and Random Forest Machine Learning
Shelli R. Kesler, Arvind Rao, Douglas W. Blayney, et al.
Frontiers in Human Neuroscience (2017) Vol. 11
Open Access | Times Cited: 79
Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?
Thibo Billiet, Louise Emsell, Mathieu Vandenbulcke, et al.
Brain Imaging and Behavior (2017) Vol. 12, Iss. 1, pp. 64-77
Closed Access | Times Cited: 65
Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review
Ashley M. Henneghan
Supportive Care in Cancer (2015) Vol. 24, Iss. 1, pp. 481-497
Closed Access | Times Cited: 58
A randomised controlled trial of manualized cognitive remediation therapy in adult obesity
Jayanthi Raman, Phillipa Hay, Kate Tchanturia, et al.
Appetite (2017) Vol. 123, pp. 269-279
Open Access | Times Cited: 55
A simplistic molecular agglomeration of carbon nitride for optimized photocatalytic performance
Asif Hayat, T.A. Taha, Asma M. Alenad, et al.
Surfaces and Interfaces (2021) Vol. 25, pp. 101166-101166
Closed Access | Times Cited: 37
Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer
Bihong T. Chen, Taihao Jin, Sunita K. Patel, et al.
Breast Cancer Research and Treatment (2018) Vol. 172, Iss. 2, pp. 363-370
Open Access | Times Cited: 38
Chemotherapy-related cognitive impairment in patients with breast cancer based on MRS and DTI analysis
Taishan Tong, Heng Lu, Jian Zong, et al.
Breast Cancer (2020) Vol. 27, Iss. 5, pp. 893-902
Closed Access | Times Cited: 33
Neurobiological changes by cytotoxic agents in mice
R. Seigers, Maarten Loos, Olaf van Tellingen, et al.
Behavioural Brain Research (2015) Vol. 299, pp. 19-26
Closed Access | Times Cited: 39
Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level
Joy Perrier, Armelle Viard, Christelle Lévy, et al.
Brain Imaging and Behavior (2018) Vol. 14, Iss. 1, pp. 226-241
Closed Access | Times Cited: 34
Cortical Brain Age from Pre-treatment to Post-chemotherapy in Patients with Breast Cancer
Ashley M. Henneghan, Vikram Rao, Rebecca A. Harrison, et al.
Neurotoxicity Research (2020) Vol. 37, Iss. 4, pp. 788-799
Open Access | Times Cited: 31
Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation
Heather M. Snyder, Tim A. Ahles, Stuart K. Calderwood, et al.
Alzheimer s & Dementia (2016) Vol. 13, Iss. 3, pp. 267-273
Open Access | Times Cited: 30
Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy
Andrew Speidell, Tamar Demby, Yi‐Chien Lee, et al.
Neurotoxicity Research (2018) Vol. 35, Iss. 2, pp. 291-303
Open Access | Times Cited: 30
Association of functional dorsal attention network alterations with breast cancer and chemotherapy
Chao‐Yu Shen, Vincent Chin‐Hung Chen, Dah‐Cherng Yeh, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic review
Haiyan Zeng, Lizza E.L. Hendriks, Wouter H. van Geffen, et al.
Cancer Treatment Reviews (2020) Vol. 88, pp. 102025-102025
Open Access | Times Cited: 26
Neurodevelopmental effects of low dose ionizing radiation exposure: A systematic review of the epidemiological evidence
Elisa Pasqual, Magda Bosch de Basea, Mònica López-Vicente, et al.
Environment International (2020) Vol. 136, pp. 105371-105371
Open Access | Times Cited: 24
Cognitive Dysfunction after Chemotherapy For Breast Cancer
Kim Edelstein, Lori J. Bernstein
Journal of the International Neuropsychological Society (2014) Vol. 20, Iss. 4, pp. 351-356
Closed Access | Times Cited: 28
Protocol for Exercise Program in Cancer and Cognition (EPICC): A randomized controlled trial of the effects of aerobic exercise on cognitive function in postmenopausal women with breast cancer receiving aromatase inhibitor therapy
Amanda Gentry, Kirk I. Erickson, Susan M. Sereika, et al.
Contemporary Clinical Trials (2018) Vol. 67, pp. 109-115
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top